Metraipolis › archive › dc_f13ce1bb1478

Biomarker-driven immunotherapy and adoptive cell therapy in recurrent pancreatic ductal adenocarcinoma — Europe PMC PMID:42662135

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42662135
DOI
10.3389/fmed.2026.1900701
License (as archived)
solo-consultazione
Archived
2026-10-16T16:00:28.948Z
SHA-256 of the archived text
620d89a06879676e48fd803253fab66ca06270989b70b37084219fea3f013ed4
Stable URL of this page
https://metraipolis.com/documento/dc_f13ce1bb1478

How to cite

Biomarker-driven immunotherapy and adoptive cell therapy in recurrent pancreatic ductal adenocarcinoma — Europe PMC PMID:42662135 — Europe PMC (en), https://europepmc.org/article/MED/42662135 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f13ce1bb1478 (Metraipolis archive dc_f13ce1bb1478, sha256 620d89a06879676e48fd803253fab66ca06270989b70b37084219fea3f013ed4)
BibTeX
@misc{dcf13ce1bb1478,
  title = {Biomarker-driven immunotherapy and adoptive cell therapy in recurrent pancreatic ductal adenocarcinoma — Europe PMC PMID:42662135},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42662135},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f13ce1bb1478; sha256 620d89a06879676e48fd803253fab66ca06270989b70b37084219fea3f013ed4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42662135. Agents can read the archived copy with the MCP tool read_document.